Overweight and obesity describe the abnormal or excessive fat accumulation that presents a risk to health. Obesity medications aim to regulate the body-weight by balancing calorie absorption, or by altering the appetite. In the past few years, Semaglutide and Liraglutide have been widely used as analogues of GLP-1 hormone to control blood sugar levels in adults.
Liraglutide, is a once-daily type-2 diabetes treatment whereas Semaglutide is a once-weekly medicine. Both can lower blood sugar levels in adults with type-2 diabetes.
Liraglutide and Semaglutide are non-insulin medications, and are not a substitute for insulin in patients who need it. Clinical studies on liragutid and Semaglutid showed very positive effects on weight loss and a promising treatment for obesity.
Liraglutide and Semaglutide are administered using a pre-filled injection pen. Start by removing the needle plastic wrap. Twist the needle until it is firmly attached to the pen. Remove the outer cap, and the inner smaller cap to expose the needle. You can then adjust the dose and inject
the needle under the skin of your abdomen. Hold it for few seconds until all the medicine dose is injected before removing.
Consult with your doctor about benefits, proper technique and of any risks or possible side effects of taking Liraglutide or Semaglutide.